Loading
Latest filing published 17 Sept 2008 for CASI Pharmaceuticals, Inc., €699.
No signal scores available.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Cynthia Wong appears in our data through filings on CASI Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 19 March 2008 to 17 September 2008.
On the market, this insider has only ever bought: 3 purchases, €3,840 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Half of the purchases are above €699 and half below. Ninety days after publication, 3 purchases show a median change of -14.5%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
The latest filing, published on 17 September 2008, reports an open-market purchase of €699 in CASI Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations